FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans VAN ISSELT

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Anatomy

Physiology

Gastric Emptying

Co-author Network

Publications

TOP 3
Frederik A Verburg; Marcel P M Stokkel; Christian Düren; Robbert B T Verkooijen; Uwe Mäder; Hans VAN ISSELT; Robert J Marlowe; Johannes W Smit; Christoph Reiners; Markus Luster
No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.
S van Esser; M Hobbelink; Hans VAN ISSELT; W P Th M Mali; I H M Borel Rinkes; R van Hillegersberg
Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer.
F A Verburg; R B T Verkooijen; M P M Stokkel; Hans VAN ISSELT
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans VAN ISSELT (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Frederik A Verburg; Marcel P M Stokkel; Christian Düren; Robbert B T Verkooijen; Uwe Mäder; Hans VAN ISSELT; Robert J Marlowe; Johannes W Smit; Christoph Reiners; Markus Luster
No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.
European journal of nuclear medicine and molecular imaging 2010;37(2):276-83.
2009: S van Esser; M Hobbelink; Hans VAN ISSELT; W P Th M Mali; I H M Borel Rinkes; R van Hillegersberg
Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer.
European journal of nuclear medicine and molecular imaging 2009;36(9):1383-7.
2009: F A Verburg; R B T Verkooijen; M P M Stokkel; Hans VAN ISSELT
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I.
Nuklearmedizin. Nuclear medicine 2009;48(4):138-42; quiz N19-20.
2009: Frederik A Verburg; Bart de Keizer; J M H de Klerk; E G W M Lentjes; C J M Lips; Hans VAN ISSELT
Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection.
Nuklearmedizin. Nuclear medicine 2009;48(1):26-9.
2008: Robbert B T Verkooijen; Frederik A Verburg; Hans VAN ISSELT; Cornelis J M Lips; Jan W A Smit; Marcel P M Stokkel
The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(3):301-7.
2008: Bart de Keizer; Georgios Arsos; Jan W Smit; Marnix G E H Lam; Inne H Borel Rinkes; roel goldschmeding; Hans VAN ISSELT
I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2008;18(3):369-71.
2007: Claudine Hunault; A C Lambers; Tjeert T Mensinga; Hans VAN ISSELT; Hans P F Koppeschaar; Jan Meulenbelt
Effects of sub-chronic nitrate exposure on the thyroidal function in humans.
Toxicology letters 2007;175(1-3):64-70.
2007: Frederik A Verburg; Bart de Keizer; Marnix G E H Lam; John M H de Klerk; Cornelis J M Lips; Inne H M Borel Rinkes; Hans VAN ISSELT
Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.
World journal of surgery 2007;31(12):2309-14.
2007: Hans VAN ISSELT; John M H de Klerk; Cornelis J M Lips
Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
European journal of nuclear medicine and molecular imaging 2007;34(11):1883-4.
2007: Zalima N Jahangier; Friso M van der Zant; J W G Jacobs; H G Riedstra; G M M Gommans; J F Verzijlbergen; J W J Bijlsma; Hans VAN ISSELT
The intra-articular distribution of 90yttrium does not influence the clinical outcome of radiation synovectomy of the knee.
Annals of the rheumatic diseases 2007;66(8):1110-2.
2007: Frederik A Verburg; Bart de Keizer; Hans VAN ISSELT
Use of radiopharmaceuticals for diagnosis, treatment, and follow-up of differentiated thyroid carcinoma.
Anti-cancer agents in medicinal chemistry 2007;7(4):399-409.
2005: Marnix G E H Lam; Hans VAN ISSELT
Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2118; author reply 2118-9.
2005: Hans VAN ISSELT
Nuclear medicine: the future is now.
Hellenic journal of nuclear medicine 2005;8(1):36-7.
2004: Hans VAN ISSELT; P Christine Oldenburg-Ligtenberg; Peter P van Rijk
Suspected thyroid stunning after radioiodine-131 scanning in a patient with a diffuse goiter.
Hellenic journal of nuclear medicine 2004;7(3):210-1.
2003: Hans VAN ISSELT; John M H de Klerk; Peter P van Rijk; Adrianus P G van Gils; Lambertus J Polman; Chris Kamphuis; Rudy Meijer; Freek J Beekman
Comparison of methods for thyroid volume estimation in patients with Graves' disease.
European journal of nuclear medicine and molecular imaging 2003;30(4):525-31.
2002: Henk Struikmans; L J E E Scheijmans; A van Dalen; M Harmelink; Paul Westers; Hans VAN ISSELT
Lateralisation and depth of the internal mammary chain determined by scintigraphy and by ultrasonography: a comparative study in 124 primary breast cancer patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;62(2):159-62.
2000: Hans VAN ISSELT; John M H de Klerk; Hans P F Koppeschaar; Peter P van Rijk
Iodine-131 uptake and turnover rate vary over short intervals in Graves' disease.
Nuclear medicine communications 2000;21(7):609-16.
1999: Rik Stokking; Hans VAN ISSELT; Peter P van Rijk; John M H de Klerk; AW Huiskes; IJ Mertens; E Buskens; Max A Viergever
Integrated visualization of functional and anatomic brain data: a validation study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):311-6.
1998: B de Vries; Martin J B Taphoorn; Hans VAN ISSELT; Chris H J Terhaard; Gerard H Jansen; P H Elsenburg
Bilateral temporal lobe necrosis after radiotherapy: confounding SPECT results.
Neurology 1998;51(4):1183-4.
1998: AW Huiskes; John M H de Klerk; Pierre M J Zelissen; Peter P van Rijk; Hans VAN ISSELT
Reverse discordant scintigraphy in diffuse goiter.
Clinical nuclear medicine 1998;23(9):588-90.
1997: H F Smits; P P Van Rijk; Hans VAN ISSELT; W P Th M Mali; H A Koomans; Peter J Blankestijn
Pulmonary embolism after thrombolysis of hemodialysis grafts.
Journal of the American Society of Nephrology : JASN 1997;8(9):1458-61.
1997: Zalima N Jahangier; J W G Jacobs; Hans VAN ISSELT; J W J Bijlsma
Persistent synovitis treated with radiation synovectomy using yttrium-90: a retrospective evaluation of 83 procedures for 45 patients.
British journal of rheumatology 1997;36(8):861-9.
1997: Melvin Samsom; L M A Akkermans; Rick J A Jebbink; Hans VAN ISSELT; Gerard P vanBerge-Henegouwen; A J P M Smout
Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus.
Gut 1997;40(5):641-6.
1997: P C Barneveld; C van Leeuwen; Hans VAN ISSELT
Scintigraphic demonstration of myocardial sarcoidosis: the added value of single-photon emission computed tomography.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 1997;4(3):256-7.
1997: John M H de Klerk; Hans VAN ISSELT; Aalt van Dijk; M E Hakman; F A Pameijer; Hans P F Koppeschaar; Pierre M J Zelissen; J P van Schaik; Peter P van Rijk
Iodine-131 therapy in sporadic nontoxic goiter.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):372-6.
1997: R M Debets; Bernard Sadzot; Hans VAN ISSELT; GJ Brekelmans; Linda C Meiners; A O van Huffelen; Georges Franck; C W M van Veelen
Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?
Journal of neurology, neurosurgery, and psychiatry 1997;62(2):141-50.
1996: Johan Vande Walle; R Donckerwolcke; Peter Boer; Hans VAN ISSELT; Hein A Koomans; Jaap A Joles
Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome.
Kidney international 1996;49(5):1471-7.
1995: Johan Vande Walle; Raymond Donckerwolcke; Hans VAN ISSELT; F H Derkx; J A Joles; Hein A Koomans
Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms.
Lancet 1995;346(8968):148-52.
1994: L M A Akkermans; Hans VAN ISSELT
Gastric motility and emptying studies with radionuclides in research and clinical settings.
Digestive diseases and sciences 1994;39(12 Suppl):95S-96S.
1994: Tjerk W A de Bruin; C D Croon; John M H de Klerk; Hans VAN ISSELT
Standardized radioiodine therapy in Graves' disease: the persistent effect of thyroid weight and radioiodine uptake on outcome.
Journal of internal medicine 1994;236(5):507-13.
1992: N M Knufman; P A van den Elsen; J P Cillessen; Hans VAN ISSELT; C A Tulleken
Spatial integration of multimodal brain images in cerebral infarction.
Brain topography 1992;5(2):165-9.
1990: Alexander C van Huffelen; Hans VAN ISSELT; C W M van Veelen; P P van Rijk; A M van Bentum; D Dive; Pierre Maquet; Georges Franck; Demetrios N Velis; Walter van Emde Boas
Identification of the side of epileptic focus with 123I-Iomazenil SPECT. A comparison with 18FDG-PET and ictal EEG findings in patients with medically intractable complex partial seizures.
Acta neurochirurgica. Supplementum 1990;50():95-9.
1989: Tom de Jong; Jan D van Gool; A A Van Wijk; P Stoutenbeek; Hans VAN ISSELT
Antenatally diagnosed obstructive uropathy--kidney imaging vs kidney function.
Acta urologica Belgica 1989;57(2):413-6.
1988: Hans VAN ISSELT
[Cow's milk protein allergy, a new disease].
Nederlands tijdschrift voor geneeskunde 1988;132(38):1763.
1987: J C Roos; Hans VAN ISSELT; M M van Buul; H Y Oei; Peter P van Rijk
The hot skull: malignant or feminine?
European journal of nuclear medicine 1987;13(4):207-9.